TCM Limited

As of June 30, 2026, TCM Limited carries a market capitalization of 336.43M, placing it among publicly traded companies globally. Its enterprise value stands at 336.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, TCM Limited has 7.48M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.57 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 336.43M versus a market cap of 336.43M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 4.32M in revenue per employee across its workforce of 49.50, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, TCM Limited's stock has declined approximately 5.71% over the past 52 weeks. The 50-day moving average sits at 46.83, while the 200-day moving average is 48.12.

Over the twelve months ended June 30, 2026, TCM Limited generated 214.08M in revenue and converted that into -51.69M in net income, yielding earnings per share of -7.01. EBITDA reached -35.22M, while operating income came in at -41.36M.

Over the twelve months ended June 30, 2026, TCM Limited posted a gross margin of 29.46, reflecting its pricing power and cost economics. The operating margin of -19.32 and net profit margin of -24.14 provide insight into operational efficiency.

TCM Limited's most recent stock split took place on April 26, 2022 with a 335:537 split ratio.